Exhaled nitric oxide and atherosclerosis

European Journal of Clinical Investigation

Volumn 42, Issue 8, 2012, Pages 873-880

  Salonen, Iiris ^a   Huttunen, Kati ^b,c   Hirvonen, Maija Riitta ^b,c   Dufva, Juhani ^d   Groundstroem, Kaj ^e   Dufva, Hilkka ^d   Salonen, Raimo O ^b  

^a Kymenlaakso Hospital Services   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d Building Services and Material Technology   (Finland)

^e KYMENLAAKSO CENTRAL HOSPITAL   (Finland)

Author keywords

Atherosclerosis; Coronary artery disease; Ischaemic heart disease; Nitric oxide

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; NITRIC OXIDE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; DISEASE ASSOCIATION; DISEASE COURSE; EXPIRED AIR; FEMALE; FRACTIONAL EXHALED NITRIC OXIDE CONCENTRATION; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRIORITY JOURNAL; RESPIRATORY TRACT PARAMETERS; RISK ASSESSMENT; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BREATH TESTS; CORONARY ARTERY DISEASE; EXHALATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; RISK FACTORS;

EID: 84864009691     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2012.02662.x     Document Type: Article

References (23)

1. Barnes PJ, Dwei RA, Gelb AF, Gibson PG, George SC, Grasemann H et al. Exhaled nitric oxide in pulmonary diseases: a comprehensive review. Chest 2010;138:682-92.
2. Shimokawa H, Tsutsui M. Nitric oxide synthases in the pathogenesis of cardiovascular disease: lessons from genetically modified mice. Invited Review. Pflugers Archiv 2010;459:959-67.
3. Simon DI, Stamler JS, Jaraki O, Keaney JF, Osborne JA, Francis SA et al. Antiplatelet properties of protein S-nitrosothiols derived from nitric oxide and endothelium-derived relaxing factor. Arterioscler Thromb 1993;13:791-9.
4. De Caterina R, Libby P, Peng H-B, Thannickal VJ, Rajavashisth TB, Gimbrone MA et al. Nitric oxide decreases cytokine-induced endothelial activation: nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995;96:60-8.
5. Zeiher AM, Fisslthaler B, Schray-Utz B, Busse R. Nitric oxide modulates the expression of monocyte chemoattractant protein I in cultured human endothelial cells. Circ Res 1995;76:980-6.
6. Wang BY, Candipan RC, Arjomandi M, Hsiun PT, Tsao PS, Cooke JP. Arginine restores nitric oxide activity and inhibits monocyte accumulation after vascular injury in hypercholesterolemic rabbits. J Am Coll Cardiol 1996;28:1573-9.
7. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989;83:1774-7.
8. Sarkar R, Meinberg EG, Stanley JC, Gordon D, Webb RC. Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circ Res 1996;78:225-30.
9. Higashi Y, Noma K, Yoshizumi M, Kihara Y. Endothelial function and oxidative stress in cardiovascular diseases. Circ J 2009;73:411-8.
10. Ignarro LJ, Napoli C. Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis. Curr Atheroscler Rep 2004;6:281-7.
11. Fichtlscherer S, Breuer S, Schächinger V, Dimmeler S, Zeiher AM. C-reactive protein levels determine systemic nitric oxide bioavailability in patients with coronary artery disease. Eur Heart J 2004;25:1412-8.
12. Rückerl R, Greven S, Ljungman P, Aalto P, Antoniades C, Bellander T et al. Air pollution and inflammation (IL-6, CRP, fibrinogen) in myocardial infarction survivors. Environ Health Perspect 2007;115:1072-80.
13. Prineas R, Crow R, Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings. Littleton, MA: John Wright-PSG Inc; 1982.
14. Pocock SJ. Clinical Trials. A Practical Approach. New York: Wiley; 1983.
15. Förstermann U. Uncoupling of nitric oxide synthase in cardiovascular disease and pharmacological reversal. In: Ignarro L, editor. Nitric Oxide. Biology and Pathobiology, 2nd edn. Burlington/San Diego/London: Elsevier Inc.; 2010: Pp 139-68.
16. Owen CG, Rudnicka AR, Nightingale CM, Mullen R, Barman SA, Sattar N. Retinal arteriolar tortuosity and cardiovascular risk factors in a multi-ethnic population study of 10-year-old children; the Child Heart and Health Study in England (CHASE). Arterioscler Thromb Vasc Biol 2011;31:1933-8.
17. Travers J, Marsh S, Aldington S, Williams M, Shirtcliffe P, Pritchard A et al. Reference ranges for exhaled nitric oxide derived from a random community survey of adults. Am J Respir Crit Care Med 2007;176:238-42.
18. Katz SD, Hryniewicz K, Hriljac I, Balidemaj K, Dimayuga C, Hudaihed A et al. Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure. Circulation 2005;111:310-4.
19. Sutherland TJ, Taylor DR, Sears MR, Cowan JO, McLachlan CR, Filsell S et al. Association between exhaled nitric oxide and systemic inflammatory markers. Ann Allergy Asthma Immunol 2007;99:534-9.
20. Albert MA, Danielson E, Rifai N, Ridker PM; PRINCE Investigators. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA 2001;286:64-70.
21. Hamer M, Steptoe A. Influence of specific nutrients on progression of atherosclerosis, vascular function, haemostasis and inflammation in coronary heart disease patients: a systematic review. Br J Nutr 2006;95:849-59.
22. Olivieri M, Talamini G, Corradi M, Perbellini L, Mutti A, Tantucci C et al. Reference values for exhaled nitric oxide (reveno) study. Respir Res 2006;7:94.
23. Nadziakiewicz P, Knapik P, Ziora D, Nowak D. Moderate exercise decreases nitric oxide exhalation in patients with stable coronary artery disease. J Physiol Pharmacol 2006;57(Suppl 4):213-21.